Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Patients access to precision oncology

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.07.18
Views: 269
Rating:

Prof Francesco de Lorenzo - European Cancer Patient Coalition (ECPC), Brussels, Belgium

Dr de Lorenzo speaks with ecancer at the 2018 WIN Symposium about the work of the European Cancer Patient Coalition (ECPC) and Cancer Control Joint Action (CanCon) in resolving the national and international disparities in access to cancer medications.

He highlights access to genomic/biomarker data and economic sustainability as key issues addressed by a recent CanCon policy paper, available here.

Dr de Lorenzo spoke with ecancer at the 2016 WIN Symposium about patient perspectives in precision medicine, here.
 

Related videos

follow us

War on Cancer 2018


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation